PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Jun-2025 VIVES Partners’ portfolio investment The Akkermansia Company (TAC) acquired by Danone Andrew Lloyd Associates
25-Jun-2025 Atrogi announces Cell paper highlighting transformative potential of muscle-targeted therapy in metabolic disease Atrogi
25-Jun-2025 OncoZenge Presents Phase 3 Study Design at MASCC/ISOO 2025 Annual Meeting OncoZenge
25-Jun-2025 Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry’s Interdisciplinary Prize Curve Therapeutics
25-Jun-2025 Actimed Therapeutics Enrols First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy Actimed Therapeutics
25-Jun-2025 Changes to Moberg Pharma´s Management Moberg
25-Jun-2025 Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Sanofi
25-Jun-2025 Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC) Janssen-Cilag
25-Jun-2025 Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies Xcell, Thermo Fisher Scientific
25-Jun-2025 Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin Fortrea
25-Jun-2025 Evaluate Releases Updated Pharmaceutical Market Forecasts in Annual World Preview Report Evaluate
25-Jun-2025 Birmingham researchers work on revolutionary approach to prevent hay fever Birmingham Biotech LTD
25-Jun-2025 Brainomix and 3DR Labs Partner to Advance Stroke Care in the US Through Clinically Validated AI Imaging Solution Brainomix
25-Jun-2025 Oxeltis and academic partners receive grant funding worth nearly €800,000 to develop antiviral for Bunyaviricetes Andrew Lloyd Associates
25-Jun-2025 New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential Carmil Therapeutics
25-Jun-2025 Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Sanofi
25-Jun-2025 New Collaboration Initiative: Alfa Chemistry Announces Inclusion as a Listed Supplier across CHEMnetBASE Dictionaries Alfa Chemistry
24-Jun-2025 Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML Enterome
24-Jun-2025 Valneva Scotland Earns Prestigious Global Health and Safety Award Valneva
24-Jun-2025 Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Priothera